SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Kadmon Holdings (KDMN)

KDMN RSS Feed
Add KDMN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/6/2017 9:27:38 PM - Followers: 5 - Board type: Free - Posts Today: 0

Healthcare-Biotech company developing kinase inhibitors for autoimmune disease, fibrosis and solid tumors.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KDMN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
KDMN News: Quarterly Report (10-q) 05/15/2017 09:29:56 AM
KDMN News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 05/15/2017 09:29:28 AM
KDMN News: Current Report Filing (8-k) 05/15/2017 09:04:18 AM
KDMN News: Kadmon Provides Business Update and Reports First Quarter 2017 Financial Results 05/15/2017 09:00:00 AM
KDMN News: Kadmon to Present Clinical & Preclinical Data Highlighting the Role of ROCK2 Signaling in Immune System Function at AAI Annua... 05/11/2017 09:00:00 AM
PostSubject
#6   Watching T695 04/06/17 09:27:38 PM
#5   Another paper, all theory and in vitro work, mcp4 08/24/16 08:19:42 AM
#4   Preclinical paper for KD025, a ROCK2 inhibitor, for mcp4 08/21/16 01:59:57 AM
#3   Insider buying! Entered today. Good pipeline IMO. vortmaximum 07/28/16 07:09:03 PM
#2   KDMN IPO reduced to 6.3M shares at $12. mcp4 07/26/16 03:11:02 PM
#1   Kadmon shares are expected to price between $16 mcp4 07/26/16 09:17:55 AM
PostSubject